瑞普生物
(300119)
| 流通市值：64.31亿 | | | 总市值：89.44亿 |
| 流通股本：3.35亿 | | | 总股本：4.66亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 451,404,509.87 | 487,366,788.05 | 347,965,744.03 | 387,177,438.27 |
| 应收票据及应收账款 | 1,115,237,832.89 | 1,070,218,782.15 | 1,068,442,700.92 | 1,026,128,413 |
| 其中：应收票据 | 11,097,244.15 | 30,429,747.69 | 35,690,521.7 | 33,223,385.96 |
| 应收账款 | 1,104,140,588.74 | 1,039,789,034.46 | 1,032,752,179.22 | 992,905,027.04 |
| 应收款项融资 | 12,267,033.56 | 7,522,354.59 | 1,871,292.15 | 15,206,575.66 |
| 预付款项 | 87,343,417.97 | 61,196,517.9 | 43,369,078.33 | 39,935,693.26 |
| 其他应收款合计 | 67,049,332.03 | 60,184,615.41 | 65,781,801.36 | 63,054,999.75 |
| 其中:应收利息 | - | 1,055,138.87 | 964,416.66 | 876,652.78 |
| 存货 | 511,261,875.85 | 499,573,319.96 | 390,213,709.48 | 393,581,454.02 |
| 其他流动资产 | 12,860,194.34 | 11,651,981.93 | 88,308,108.54 | 17,348,073.2 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 3,725,458,129.66 | 3,648,969,542.58 | 3,348,371,664.99 | 3,074,979,408.23 |
| 非流动资产: | | | | |
| 长期应收款 | 1,336,892.12 | 1,455,756.02 | - | - |
| 长期股权投资 | 1,093,106,799.38 | 1,068,859,364.7 | 457,374,613.02 | 458,463,831.48 |
| 其他非流动金融资产 | 116,644,534.04 | 100,368,039.13 | 626,771,869.94 | 626,562,102.41 |
| 投资性房地产 | 36,464,893.27 | 37,463,120.35 | 38,461,347.41 | 39,459,574.5 |
| 固定资产 | 1,808,249,950.52 | 1,845,590,552.43 | 1,810,808,671.14 | 1,834,582,521.35 |
| 在建工程 | 75,275,598.53 | 62,690,187.68 | 101,693,464.75 | 100,758,393.74 |
| 使用权资产 | 15,038,380.06 | 17,371,440.42 | 12,505,151.49 | 14,508,358.83 |
| 无形资产 | 485,690,665.29 | 493,138,512.76 | 497,418,936.32 | 505,617,997.23 |
| 开发支出 | 197,421,816.35 | 192,998,232.44 | 181,978,059.49 | 175,409,588.81 |
| 商誉 | 443,364,365.47 | 442,263,365.47 | 312,238,524.11 | 312,238,524.11 |
| 长期待摊费用 | 1,000,398.55 | 944,104.11 | 329,685.76 | 235,829.69 |
| 递延所得税资产 | 27,955,377.57 | 26,948,735.01 | 22,450,744.22 | 20,213,037.06 |
| 其他非流动资产 | 35,337,389.9 | 26,732,100.77 | 25,381,877.26 | 32,807,746.26 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 4,336,887,061.05 | 4,316,823,511.29 | 4,087,412,944.91 | 4,120,857,505.47 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 8,062,345,190.71 | 7,965,793,053.87 | 7,435,784,609.9 | 7,195,836,913.7 |
| 流动负债: | | | | |
| 短期借款 | 735,362,949.66 | 800,781,866.94 | 688,293,806.34 | 696,398,714.67 |
| 应付票据及应付账款 | 641,048,294.4 | 550,239,664.56 | 472,272,042.63 | 467,811,524.1 |
| 其中：应付票据 | 284,209,449.39 | 187,368,279.18 | 120,580,395.2 | 114,971,474.1 |
| 应付账款 | 356,838,845.01 | 362,871,385.38 | 351,691,647.43 | 352,840,050 |
| 预收款项 | 7,177,492.07 | 8,316,964.05 | 124,256.04 | 88,969.03 |
| 合同负债 | 38,211,941.5 | 48,111,143.45 | 36,367,202.67 | 52,530,762.55 |
| 应付职工薪酬 | 39,257,793.25 | 67,194,592.49 | 31,107,277.12 | 31,152,494.97 |
| 应交税费 | 25,070,276.42 | 24,556,844.81 | 37,107,803.15 | 28,432,954.21 |
| 其他应付款合计 | 578,368,358.71 | 660,575,397.75 | 405,047,346.52 | 373,867,760.64 |
| 应付股利 | 30,806,489.25 | 23,905,106.19 | 35,727,106.19 | 13,622,000 |
| 一年内到期的非流动负债 | 60,417,538.73 | 61,077,080.98 | 36,927,605.14 | 27,211,988.24 |
| 其他流动负债 | 13,297,401.1 | 29,975,299.38 | 34,058,827.79 | 26,190,502.98 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 2,138,212,045.84 | 2,250,828,854.41 | 1,741,306,167.4 | 1,703,685,671.39 |
| 非流动负债: | | | | |
| 长期借款 | 643,110,206.4 | 513,813,058.96 | 548,818,610.41 | 424,516,701.86 |
| 租赁负债 | 5,647,751.2 | 5,247,839.55 | 717,811.51 | 4,692,493.75 |
| 递延收益 | 60,907,071.56 | 63,132,905.4 | 61,909,605.66 | 57,192,061.48 |
| 递延所得税负债 | 130,931,204.25 | 125,810,337.7 | 125,184,738.09 | 122,776,335.6 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 840,596,233.41 | 708,004,141.61 | 736,630,765.67 | 609,177,592.69 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,978,808,279.25 | 2,958,832,996.02 | 2,477,936,933.07 | 2,312,863,264.08 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 465,847,906 | 465,847,906 | 465,847,906 | 466,276,186 |
| 资本公积 | 2,157,087,494.68 | 2,157,087,494.68 | 2,190,777,091.49 | 2,193,919,637.48 |
| 减:库存股 | 191,871,797.65 | 171,875,332.65 | 71,887,282.66 | 76,063,012.66 |
| 盈余公积 | 232,923,953 | 232,923,953 | 232,291,974.82 | 232,291,974.82 |
| 未分配利润 | 1,901,990,815.32 | 1,786,006,157.36 | 1,732,853,419.99 | 1,647,256,274.43 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 4,565,978,371.35 | 4,469,990,178.39 | 4,549,883,109.64 | 4,463,681,060.07 |
| 少数股东权益 | 517,558,540.11 | 536,969,879.46 | 407,964,567.19 | 419,292,589.55 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,083,536,911.46 | 5,006,960,057.85 | 4,957,847,676.83 | 4,882,973,649.62 |
| 负债和股东权益合计 | 8,062,345,190.71 | 7,965,793,053.87 | 7,435,784,609.9 | 7,195,836,913.7 |
| 公告日期 | 2025-04-26 | 2025-04-03 | 2024-10-30 | 2024-08-24 |
| 审计意见(境内) | | 标准无保留意见 | | |